Amphastar Pharmaceuticals (29A.F) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.71
0.79
0.88
0.97

Details

Expected EPS
0.90671724
Actual EPS
0.8810208
Surprise EPS
-0.03
Surprise Percent
+2.83%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.8810208 per share for Q4 2024.

0 Comments

Share your thoughts